What is it about?
This 13‑year national study shows hepatitis B and C infections are declining among Brunei’s kidney dialysis patients, supporting progress towards hepatitis micro‑elimination in a high‑risk group.
Featured Image
Photo by Mufid Majnun on Unsplash
Why is it important?
This work offers one of the first comprehensive, nationwide picture of hepatitis B and C trends in a high-risk dialysis group by connecting national dialysis and transplant data with Brunei's electronic health records. It shows that an organised micro-elimination technique can achieve sustained decreases in a small, high-income Asian setting. These findings provide a useful, policy-relevant model as nations step up efforts to reach the WHO's 2030 hepatitis elimination targets, especially for small and middle-income health systems. Researchers, decision-makers, and health journalists may rapidly see what succeeded, where there are still gaps, and how the strategy might be modified elsewhere when this evidence is presented in an understandable manner.
Perspectives
This article emphasises how investments in health information systems, governance, and interdisciplinary collaboration can directly inform national hepatitis elimination efforts, in my opinion as a health-policy and planning expert in Brunei. It supports the idea that robust routine data and unambiguous indicators are essential components of a robust health system, allowing for progress monitoring, gap analysis, and focused intervention for high-risk groups like dialysis patients.
Lubna Razak
Brunei Ministry of Health
Read the Original
This page is a summary of: National progress towards hepatitis B and C micro-elimination in a high-risk haemodialysis population: The Brunei Darussalam experience, Asian Pacific Journal of Tropical Medicine, September 2026, Wolters Kluwer Health,
DOI: 10.4103/apjtm.apjtm_323_26.
You can read the full text:
Contributors
The following have contributed to this page
